Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine Stent Placement Following Hysteroscopic Septum Resection
NCT07032506Recruiting
- Sponsor
- Weill Cornell Medicine
- Start
- May 2026
- Primary completion
- Sep 2029
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Rate of intrauterine adhesion formation at 12 weeks. Started May 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07032506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07032506.